Pages that link to "Q28373358"

The following pages link to Haloperidol-induced catalepsy is absent in dopamine D(2), but maintained in dopamine D(3) receptor knock-out mice (Q28373358):

Displayed 28 items.

• Distinct functions of the two isoforms of dopamine D2 receptors (Q28138415) ‎ (← links)
• Cannabinoid action depends on phosphorylation of dopamine- and cAMP-regulated phosphoprotein of 32 kDa at the protein kinase A site in striatal projection neurons (Q28272251) ‎ (← links)
• Facilitated glutamatergic transmission in the striatum of D2 dopamine receptor-deficient mice (Q28590689) ‎ (← links)
• Zebrafish behavioral profiling identifies multitarget antipsychotic-like compounds. (Q30369007) ‎ (← links)
• Glycogen synthase kinase-3β inhibition in the medial prefrontal cortex mediates paradoxical amphetamine action in a mouse model of ADHD. (Q30414710) ‎ (← links)
• Dual control of dopamine synthesis and release by presynaptic and postsynaptic dopamine D2 receptors (Q30450310) ‎ (← links)
• The glycine transporter-1 inhibitor SSR103800 displays a selective and specific antipsychotic-like profile in normal and transgenic mice (Q30475523) ‎ (← links)
• GPR37 associates with the dopamine transporter to modulate dopamine uptake and behavioral responses to dopaminergic drugs. (Q30479554) ‎ (← links)
• The role of GRK6 in animal models of Parkinson's disease and L-DOPA treatment (Q30506209) ‎ (← links)
• Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP). (Q30856987) ‎ (← links)
• Involvement of Basal Ganglia network in motor disabilities induced by typical antipsychotics (Q33480027) ‎ (← links)
• Pitx3-deficient aphakia mice display unique behavioral responses to psychostimulant and antipsychotic drugs (Q33743731) ‎ (← links)
• The psychopharmacology-molecular biology interface: exploring the behavioural roles of dopamine receptor subtypes using targeted gene deletion ('knockout'). (Q34268520) ‎ (← links)
• Genetic animal models: focus on schizophrenia (Q34338239) ‎ (← links)
• Fyn is required for haloperidol-induced catalepsy in mice (Q34483692) ‎ (← links)
• Dopaminergic mouse mutants: investigating the roles of the different dopamine receptor subtypes and the dopamine transporter (Q35144772) ‎ (← links)
• Structure-activity relationships for a novel series of dopamine D2-like receptor ligands based on N-substituted 3-aryl-8-azabicyclo[3.2.1]octan-3-ol (Q35168503) ‎ (← links)
• LAMP5 Fine-Tunes GABAergic Synaptic Transmission in Defined Circuits of the Mouse Brain (Q36043739) ‎ (← links)
• Phenotypic studies on dopamine receptor subtype and associated signal transduction mutants: insights and challenges from 10 years at the psychopharmacology-molecular biology interface. (Q36205868) ‎ (← links)
• Heart-type fatty acid binding protein regulates dopamine D2 receptor function in mouse brain (Q39735652) ‎ (← links)
• Dopamine D1 and D2 antagonist effects on response likelihood and duration (Q41832853) ‎ (← links)
• Selective excitation of GABAergic neurons in the substantia nigra of the rat by orexin/hypocretin in vitro. (Q43878301) ‎ (← links)
• The acute EPS of haloperidol may be unrelated to its metabolic transformation to BCPP + (Q44614180) ‎ (← links)
• Combined treatment of ascorbic acid or alpha-tocopherol with dopamine receptor antagonist or nitric oxide synthase inhibitor potentiates cataleptic effect in mice. (Q46418503) ‎ (← links)
• CK2 Oppositely Modulates l-DOPA-Induced Dyskinesia via Striatal Projection Neurons Expressing D1 or D2 Receptors (Q47447585) ‎ (← links)
• Differential regulation of striatal motor behavior and related cellular responses by dopamine D2L and D2S isoforms (Q49645236) ‎ (← links)
• Characterization of the quantitative trait locus for haloperidol-induced catalepsy on distal mouse chromosome 1 (Q56602241) ‎ (← links)
• The mammalian target of rapamycin (mTOR) kinase mediates haloperidol-induced cataleptic behavior (Q100427915) ‎ (← links)